SBIR/STTR Research Award
Development of live attenuated respiratory syncytial virus vaccines with novel thermal stable fusion protein
Award amount
$1,339,319Program and phase
SBIR · Phase IIAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- MEISSA VACCINES INC
- Proposal award date
- 2018-02-01
- Contract end date
- 2019-07-31
- UEI
- NWHJJVLRVAZ8
- Solicitation number
- PA16-302
- Topic code
- NIAID
Research abstract
Respiratory syncytial virusRSVis the most important pathogen for lower respiratory tract infection in infantsbut there are no approved vaccinesRSV live attenuated vaccinesLAVare the most clinically advanced candidates but have two main problemslack of potency and genetic instabilityThis study will compare two novel RSV LAVs with improved potency and stability in relevant pre clinical modelsin preparation for taking a lead candidate to clinical trial
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of live attenuated respiratory syncytial virus vaccines with novel thermal stable fusion protein
- Development of polyvalent inactivated rhinovirus vaccine
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail
- A first-in-class product for the clearance of high-risk human papillomaviruses
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- Optimization, Pharmacokinetics, and Efficacy of an IgG Protease for the Treatment of Immune Thrombocytopenia and Other IgG-Mediated Autoimmune Diseases
- Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients
Research funding history
3 SBIR/STTR records share this UEI (2017–2018). Reported award amounts total $1,779,800. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services